إستراتيجية الاندماج كآلية لتحسين الميزة التنافسية للمؤسسة : دراسة حالة اندماج شركتي "فايزر" و "أليرغان"

Abstract EN

There are many strategies for companies to improve their competitive advantage and ensure their survival in the market as competition intensifies, merger is one of the most important strategies of diversification, which has seen a wide spread among institutions especially since the beginning of the third millennium and the growing importance of major economic entities.

This paper aims to describe and analyze the merger strategy as a mechanism for companies to improve the various indicators of competitive advantage by benefiting from the synergy in the light of the experience of the merger of Pfizer and Allergen in the pharmaceutical industry.